Westerkirk Capital »

United Therapeutics Corporation shares owned by Westerkirk Capital

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Westerkirk Capital from 13F filings

Historical chart of Westerkirk Capital investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Westerkirk Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Westerkirk Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $208k 495 419.21
2025-06-30 $142k 495 287.35

More positions owned by Westerkirk Capital

Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Mastercard Incorporated Cl A (MA)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
Netflix (NFLX)
Alphabet Cap Stk Cl A (GOOGL)
TJX Companies (TJX)
Canadian Pacific Kansas City (CP)

View all positions for Westerkirk Capital

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Assetmark
Invesco
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation